Cargando…

Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study

Current morphologic features defining advanced adenomas (size ≥10 mm, high-grade dysplasia or ≥25% villous component) cannot optimally distinguish individuals at high risk or low risk of metachronous colorectal cancer (me-CRC), which may result in suboptimal surveillance. Certain DNA copy-number alt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jodal, Henriette C., Akwiwu, Eddymurphy U., Lemmens, Margriet, Delis-van Diemen, Pien M., Klotz, Dagmar, Leon, Leticia G., Lakbir, Soufyan, de Wit, Meike, Fijneman, Remond J.A., van Leerdam, Monique E., Dekker, Evelien, Spaander, Manon C.W., Meijer, Gerrit A., Løberg, Magnus, Coupé, Veerle M.H., Kalager, Mette, Carvalho, Beatriz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642372/ https://www.ncbi.nlm.nih.gov/pubmed/37921412 http://dx.doi.org/10.1158/2767-9764.CRC-23-0186

Ejemplares similares

A progressive three-state model to estimate time to cancer: a likelihood-based approach
por: Akwiwu, Eddymurphy U., et al.
Publicado: (2022)

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer
por: van den Broek, Evert, et al.
Publicado: (2018)

Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer
por: de Wit, Meike, et al.
Publicado: (2012)

Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression
por: de Wit, Meike, et al.
Publicado: (2017)

Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum
por: Greijer, Astrid E., et al.
Publicado: (2008)

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study
por: den Uil, Sjoerd H., et al.
Publicado: (2019)

A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9
por: Goos, Jeroen A.C.M., et al.
Publicado: (2015)

Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression
por: Sillars-Hardebol, Anke H., et al.
Publicado: (2010)

Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis
por: Nugteren, Sandrine, et al.
Publicado: (2020)

Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases
por: Bolhuis, Karen, et al.
Publicado: (2021)

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence
por: den Uil, Sjoerd H, et al.
Publicado: (2016)

Emergency hospital admissions, prognosis, and population mortality in Norway during the first wave of the Covid-19 epidemic
por: Jodal, Henriette C., et al.
Publicado: (2022)

High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence
por: Nugteren, Sandrine, et al.
Publicado: (2022)

The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care
por: van der Meijde, Elisabeth, et al.
Publicado: (2016)

Consensus molecular subtype classification of colorectal adenomas
por: Komor, Malgorzata A, et al.
Publicado: (2018)

KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer
por: Uil, Sjoerd H., et al.
Publicado: (2022)

Mortality in Norway and Sweden during the COVID-19 pandemic
por: Juul, Frederik E., et al.
Publicado: (2021)

Proteins in stool as biomarkers for non‐invasive detection of colorectal adenomas with high risk of progression
por: Komor, Malgorzata A, et al.
Publicado: (2020)

Paving the Road Towards Non-Invasive Molecular Imaging
por: Fijneman, Remond J.A.
Publicado: (2006)

Genetic Predisposition to Sporadic Cancer: How to Handle Major Effects of Minor Genes?
por: Fijneman, Remond J. A.
Publicado: (2005)

CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients
por: Vleugels, Jasper L.A., et al.
Publicado: (2019)

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients
por: Lenos, Kristiaan, et al.
Publicado: (2015)

Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin
por: van Oudheusden, T. R., et al.
Publicado: (2015)

Inequality of opportunity in selection procedures limits diversity in higher education: An intersectional study of Dutch selective higher education programs
por: Mulder, Lianne, et al.
Publicado: (2023)

The cumulative false-positive rate in colorectal cancer screening: a Markov analysis
por: Haug, Ulrike, et al.
Publicado: (2020)

Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression
por: Komor, Malgorzata A., et al.
Publicado: (2019)

Diversity in the pathway from medical student to specialist in the Netherlands: a retrospective cohort study
por: Mulder, Lianne, et al.
Publicado: (2023)

Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC
por: Sluiter, Nina R., et al.
Publicado: (2018)

Benefits and harms of mammography screening
por: Løberg, Magnus, et al.
Publicado: (2015)

Reply to: Letter to the Editor regarding "Covid-19 transmission in fitness centers in Norway—a randomized trial"
por: Helsingen, Lise M., et al.
Publicado: (2022)

Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2022)

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
por: Goos, J A C M, et al.
Publicado: (2013)

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases
por: Goos, J A C M, et al.
Publicado: (2014)

The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic
por: Kortlever, Tim L., et al.
Publicado: (2021)

Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
por: de Krijger, Manon, et al.
Publicado: (2022)

Prediction of Microscopic Metastases in Patients with Metachronous Oligo-Metastases after Curative Treatment of Non-Small Cell Lung Cancer: A Microsimulation Study
por: Wolff, Henri B., et al.
Publicado: (2021)

Risk of hepato‐pancreato‐biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population‐based cohort study
por: Yu, Jingru, et al.
Publicado: (2022)

Cost-effectiveness of the SEN-concept: Specialized Emergency Nurses (SEN) treating ankle/foot injuries
por: Derksen, Robert J, et al.
Publicado: (2007)

Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice
por: Razenberg, L. G. E. M., et al.
Publicado: (2016)

Polypectomy techniques among gastroenterologists in Norway – a nationwide survey
por: Pedersen, Ina B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f2j22sike81tl4p6jl86duaf9q